Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BRUKER CORP Director's Dealing 2023

May 10, 2023

31067_dirs_2023-05-10_7a3672bc-6a68-4ffb-b9d9-0f8e4b14bca9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BRUKER CORP (BRKR)
CIK: 0001109354
Period of Report: 2023-05-08

Reporting Person: LAUKIEN FRANK H (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-05-08 Common Stock S 81745 $76.99 Disposed 38352034 Direct
2023-05-08 Common Stock S 6832 $77.71 Disposed 38262287 Direct
2023-05-08 Common Stock S 441 $78.53 Disposed 38210993 Direct
2023-05-09 Common Stock S 30359 $74.44 Disposed 38180634 Direct
2023-05-09 Common Stock S 70598 $75.39 Disposed 38110036 Direct
2023-05-09 Common Stock S 10025 $76.12 Disposed 38100011 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1046499 Indirect
Common Stock 337087 Indirect
Common Stock 336607 Indirect
Common Stock 201702 Indirect
Common Stock 71728 Indirect
Common Stock 492 Indirect

Footnotes

F1: The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.50 to $77.49, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.50 to $78.49, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.50 to $78.53, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.925 to $74.91, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.92 to $75.91, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.92 to $76.31, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote

F8: The Reporting Person disclaims beneficial ownership of 1,046,499 shares held by the Reporting Person's former spouse- Robyn Laukien, 492 shares held by the Reporting Person's former spouse- Ruta Laukien, 337,087 shares held by the Reporting Person's adult son and 336,607 shares held by the Reporting Person's adult daughter, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.